Quince Therapeutics, Inc. (QNCX)
Market Closed
9 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
31. 73
+2.37
+8.0722%
Pre Market
$
+1.5 +4.7274% 33. 23
8.83M Market Cap
- P/E Ratio
- Div Yield
138,744 Volume
0 Eps
$ 29.36
Previous Close 
Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Quince Therapeutics, Inc. (QNCX) Statistics
Valuation metrics
Market Cap 8.83M
Enterprise value -107.15M
Trailing P/E (ttm) -0.46
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 1.79
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 138.7K
Average volume (90 days) 47.46K
Price summary
52-Week low 15.1
52-Week high 910
Beta -
50-Day moving average 30.58
200-Day moving average 5.63
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 30 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.75%
Return on equity -4.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -15.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 18.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 14.52%
Book value per share (mrq) 17.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
